Press release
Non-invasive Prenatal Testing Market is Prognosticate to Reach a Value of US$ 2.38 Billion by 2022
Read Report Overview @ https://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
The global NIPT market is analyzed on the basis of the tests and the regional distribution of this market. Based on tests, the market is broadly classified into BambniTest, informaSeq, Harmony, MaterniT21 PLUS, Panorama, NIFTY, PrenaTest, VisibiliT, and verifi. Regionally, the worldwide market for NIPT is distributed among North America, Asia Pacific, Europe, and the Rest of the World.
The report present a comprehensive study of the global NIPT market with an analytical approach. Market drivers, restraints, opportunities, current and upcoming trends, and various segmentations of this market has been discussed at length in this study, making it a valuable source of guidance for market participants.
The global NIPT market stood at US$0.5 bn in 2013. Expanding at a CAGR of 17.50% over the period from 2014 to 2022, the market is projected to reach US$2.38 bn by the end of the forecast period.
According to the report, the first non-invasive prenatal test launched in the market was MaterniT21 PLUS. The test was introduced in 2011 and was intended to diagnose trisomy 21. In 2013, the market for MaterniT21 PLUS accounted for 36.1% of the total revenue generated in the NIPT market across the globe. However, this market segment is likely to lose ground on account of rising commercialization of panorama, Verifi, Bambni, and NIFTY during the forecast period.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374
The NIPT market in North America emerged as the largest regional market of the global NIPT market in 2013 with a 58.8% share in terms of revenue and a 51% share in terms of volume. The presence of major market participants in the U.S. and a high level of awareness pertaining to NIPT in North America has boosted the regional market extensively.
The Asia Pacific NIPT market is showing immense potential for growth. Australia, Japan, India, and China are the key markets for NIPT in this region. A large population base of women choosing late pregnancy is expected to drive the Asia Pacific market for NIPT market over the forecast period.
The presence of untapped opportunities in developing economies across the globe provides a huge potential market for participants. However, the strict regulatory guidelines regarding non-invasive prenatal testing and the availability of alternative screening and testing procedures are likely inhibit the growth of the market to an extent.
Laboratory Corporation of America Holdings, Berry Genomics Co. Ltd., Illumina Inc., LifeCodexx AG, Sequenom Inc., BGI Diagnostics, Ariosa Diagnostics Inc., and Natera Inc. are the major companies functioning in the global NIPT market. Strategic partnership and alliance with hospitals, medical research centers, and clinical laboratories are the key trends among the market participants for the expansion of their business.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=374
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-invasive Prenatal Testing Market is Prognosticate to Reach a Value of US$ 2.38 Billion by 2022 here
News-ID: 1170180 • Views: …
More Releases from Transparency Market Research
Transformer Dismantling & Recycling Services Market Outlook 2034: How Sustainabl …
As global energy systems evolve and electricity demand rises, the safe, efficient, and environmentally responsible disposal of aging electrical infrastructure has become an urgent priority. Transformers-critical components of transmission and distribution networks-must be replaced or refurbished regularly due to wear, efficiency loss, safety concerns, or regulatory mandates. Transformer dismantling and recycling services play a vital role in ensuring that these large, complex electrical units are decommissioned safely while valuable materials…
Online Dating Services Market Outlook 2034: How Digital Matchmaking Platforms Ar …
The online dating services market has undergone a remarkable transformation over the past decade, evolving from simple matchmaking websites to highly intelligent, data-driven platforms that use artificial intelligence, behavioral insights, and preference-based algorithms to match users more effectively. The rise of mobile apps, digital socialization, and increased acceptance of online dating across age groups has made digital matchmaking a mainstream phenomenon. In 2023, the global online dating services market was…
Ambulatory Infusion Centers Market Outlook 2035: Transforming Outpatient Care Th …
Ambulatory infusion centers (AICs) have become one of the most rapidly expanding components of modern healthcare, driven by a growing emphasis on outpatient care solutions, the rising prevalence of chronic diseases, and increasing adoption of advanced biologics. These specialized centers provide infusion therapies outside of hospital settings, offering patients convenience, affordability, and improved treatment experiences. As healthcare systems worldwide shift toward models that prioritize cost savings, patient comfort, and efficient…
Amyloidosis Therapeutics Market Outlook 2035: Advancements in Rare Disease Treat …
The global healthcare landscape is witnessing a growing focus on rare diseases, propelled by increasing awareness, expanded diagnostic capabilities, and advancements in personalized medicine. Amyloidosis, a group of rare but severe conditions caused by the buildup of abnormal amyloid proteins in tissues and organs, has moved into the spotlight as medical science uncovers more effective treatments and diagnostic tools. The amyloidosis therapeutics market, valued at US$ 2.7 billion in 2024,…
More Releases for NIPT
Noninvasive Prenatal Testing (NIPT) Market | Counsyl, Illuminansyl, Intergrated …
The global noninvasive prenatal testing (nipt) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the noninvasive prenatal testing (nipt) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving…
Noninvasive Prenatal Testing (NIPT) Market global outlook and forecast 2021 -202 …
The Global Noninvasive Prenatal Testing (NIPT) Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Noninvasive Prenatal Testing (NIPT) makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The…
Non Invasive Prenatal Testing (NIPT) Market Worth $13.1 Billion by 2027
Meticulous Research- leading global market research company published a research report titled "Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global Forecast to 2027". According to this latest publication from Meticulous Research, the global non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019…
Non-Invasive Prenatal Testing Market has been analyzed from 2 viewpoints: NIPT T …
Worldwide Market Reports recently released “Global Non-Invasive Prenatal Testing Market Research Report 2017” that centers around the latest developing trends and technologies in the Non-Invasive Prenatal Testing Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022.
During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives…
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports.
NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at a…
Non-Invasive Prenatal Testing (NIPT) Market Forecast 2017-2021
Non-invasive prenatal testing (NIPT) has received importance in the recent past due to increasing awareness about genetic disorders and availability of accurate noninvasive tests. NIPT testing is non-invasive has no risk of miscarriage as compared to other tests such as chorionic villus sampling (CVS) or amniocentesis. Down syndrome is one of most commonly diagnosed using NIPT. Some of the key genetic disorders diagnosed using NIPT include Edward's syndrome, Patau syndrome…
